Verified peer comparison
IB Acquisition vs Scinai Immunotherapeutics Financial Comparison
Direct answer
IB Acquisition and Scinai Immunotherapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free IB Acquisition email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- IB Acquisition Revenue
- 0 USD
- Scinai Immunotherapeutics Revenue
- 1,311,000 USD
- IB Acquisition Operating income
- -748,908 USD
- Scinai Immunotherapeutics Operating income
- -7,542,000 USD